|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
FY2023
12 months to Oct 31, 2023
|
FY2022
12 months to Oct 31, 2022
|
FY2021
12 months to Oct 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses | |||||
| General and administrative | |||||
| Professional, other fees and salaries | |||||
| Statute barred payables | |||||
| Stock-based compensation | |||||
| Travel and entertainment | |||||
| Depreciation of property and equipment | |||||
| Amortization of patents | |||||
| Foreign exchange loss (gain) | |||||
| Total operating expenses | |||||
| Other expenses (income) | |||||
| Accretion expense | |||||
| Interest expense | |||||
| Financing costs | |||||
| Other finance expenses | |||||
| Loss (gain) on revaluation of warrant liabilities | |||||
| Loss (gain) on debt settlement | |||||
| Impairment of inventory | |||||
| Loss (gain) on revaluation of derivative liabilities | |||||
| Loss (gain) on conversion of convertible debentures | |||||
| Loss on extinguishment of convertible debentures | |||||
| Loss (gain) on repayment of convertible debentures | |||||
| Loss (gain) on extinguishment of convertible debentures | |||||
| Total other expenses (income) | |||||
| Loss before income tax provision | |||||
| Income tax provision | |||||
| Net loss and comprehensive loss | |||||
| Weighted average number of outstanding shares, basic (in shares) | |||||
| Weighted average number of outstanding shares, diluted (in shares) | |||||
| Loss per share, basic | |||||
| Loss per share, diluted | |||||
Loading...